Navigation Links
Using additional biopsy-scoring data may help determine prostate cancer prognosis
Date:10/2/2007

d a significantly shorter time to PSA failure than men with 7 without tertiary grade 5 (median [midpoint] time, 5.0 vs. 6.7 years, respectively); or score of 6 or less (median time, 15.4 years). However, a significant difference was not observed when these men were compared with men with Gleason score 8 to10 disease (median time, 5.1 years).

If these findings are validated by additional studies in other populations, they may affect the management of care for men with Gleason score 7 prostate cancer for which the currently practiced management standards include dose-escalated radiation therapy including prostate brachytherapy [radiation therapy where the radioactive source is placed inside the prostate] with or without supplemental radiation therapy, radiation therapy and short course androgen suppression therapy (AST) or radical prostatectomy. Specifically, given the time to recurrence, management options for men with Gleason score 7 who also have tertiary grade 5 disease could include treatments that are the current standards of care for men with Gleason 8 to 10 prostate cancer, the authors write.

These standards of care based on the results of randomized trials include radiation therapy and short- or extended-course AST or radical prostatectomy with the expectation that further therapy may be needed postoperatively depending on the final pathology findings of the radical prostatectomy and postoperative PSA level.


'/>"/>

Contact: Lori Shanks
617-534-1604
JAMA and Archives Journals
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Poor health care in Russia maybe causing Decline in its Population
2. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
3. Researchers urge caution in using ear tube surgery
4. Surgery using gene therapy for Alzheimer’s patient
5. Protein causing spread of colon cancer identified
6. Relief to pregnant women using fertility drugs
7. The hazards of using disinfectant hand gel
8. Ulcer causing bug found in stored food
9. Colon cancer risk linked to genes causing Hemochromatosis
10. Teens Misusing Nicotine-Replacement Products
11. Head injury X-rays may actually be causing harm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2008)...t, salt a quick fix without losing taste, experts ...s) -- You can eat healthier this holiday season by...y experts with the Texas AgriLife Extension Servic...r salt content of almost any holiday recipe withou...ialist Mary Bielamowicz said in a news release. ,...
(Date:11/21/2008).... 21 Album Creative Studios, Inc.,...ew program offering big brand marketing for small ...xpensive ad agency process and services, and tailo...approach," says Matt Parker, Creative Director. ...nce and proven brand-building techniques to build ...
(Date:11/21/2008)...lders to be held on January 8, 2009 , , TOR...nternational Inc. ("MedEmerg") (OTCBB: MDER), one ...announced today that it has obtained an interim or...cerning its previously announced plan of arrangeme...h Group Inc. ("AIM") will acquire all of MedEmerg,...
(Date:11/21/2008)...PRNewswire-USNewswire/ -- During a memorial servi...dell today remembered Lieutenant Governor Catherin...partner in public service, and a tireless advocate...e first woman elected lieutenant governor, Catheri...overnor Rendell. "Her family and her faith were dr...
Breaking Medicine News(10 mins):Health News:Substitutions Make Holiday Fare Healthier 2Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3
...urgeon at London's Middlesex Hospital, advices pas...nothing to fear. The death of a woman on board an ...ght, has sparked off this sudden debate that long ...ople. Dr. Scurr says this fear is unfounded and th...
... the common white patches found inside the mouth c...etic test can help pinpoint if the patches could b...y of Oslo spearheaded this research. If identified... patches are known, can be cured and the occurrenc...
...ps are too small to be picked up by a mammogram, t...candidate for breast cancer. But to offset this pr...School of Medicine, Baltimore headed by Dr. Sarasw...ing early stages of breast cancer by using a new m...
...reast cancer, may opt for mastectomy over breast-c...reast cancer gene mutation, researchers said Calif...cers are caused by an inherited genetic susceptibi... linked to mutations or alterations in two genes, ...
Other Medicine News:
(Date:11/20/2008)...Calif., Nov. 20 Duska Th...ounced today that it has submitted its,pivotal Ph...der a Special,Protocol Assessment (SPA) procedure.... , Subject to securing an agreement with t...ective, double-blind, placebo-controlled and rando...
(Date:11/19/2008)...SCO, Nov. 19 Posit Science Corpora...t the Society for Neuroscience,Annual Conference ...ive,training may benefit Baby Boomers. The compu...ram (TM) uses adaptive exercises that target audit...gned to drive generalized,improvements in cogniti...
(Date:11/19/2008)...l., Nov. 19 Isogen, a contract dev...le filling, today announced the first,phase launc... founded to,specifically address the process, fac...ith the $2 billion highly-niched, low-volume clini...rket segment. , Companies can invest over $...
(Date:11/18/2008)... Va., Nov. 18 Forty-two... at a November national forum to consider cutting-...health and national economy from outbreaks of dang... today. , , Among those innovations: , ...rican kitchen table that detects highly contagious...
Breaking Medicine Technology:Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Isogen Launches Major New Facility to Address Global Biopharma Demand 242 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 1741 1Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 1741 2Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 1741 3Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 1741 4Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 1741 5Pharmaceuticals 26 Biotechs to Share Insights for Developing Leaders in a Fast Paced Competitive Industry 4533 1Pharmaceuticals 26 Biotechs to Share Insights for Developing Leaders in a Fast Paced Competitive Industry 4533 2Longs Reports Preliminary March Retail Drug Store Sales 16546 1Longs Reports Preliminary March Retail Drug Store Sales 16546 2LeMaitre Vascular Announces Changes to Its Executive Management Team 16541 1LeMaitre Vascular Announces Changes to Its Executive Management Team 16541 2
... of the American Society of,Clinical Oncology -- ,...rmaceuticals,Inc. (Nasdaq:SCLN) and Sigma-Tau S.p...ndidate thymalfasin (ZADAXIN(r), thymosin,alpha 1)...al trial,treating patients diagnosed with stage IV...n cancer. Results showed that thymalfasin,in combi...
...Can Inhibit Breast Cancer,Growth By 75%, DALLAS an...all/,-- Access Pharmaceuticals, Inc. (Bulletin Boa...tin Board: SMPM) announced today that a,scientific...for,Somanta,s Angiolix has been selected for publi...iety of Clinical Oncology,(ASCO) Annual Meeting to...
Other Medicine Technology:Access and Somanta Announce Data to be Presented on Angiolix at,ASCO Oncology Conference 2Access and Somanta Announce Data to be Presented on Angiolix at,ASCO Oncology Conference 3
...he Portex® Thermovent® T helps provide pro...patient. It is small and extremely lightweight mak...adults. With a high rate of heat and moisture reco...tion retention., ,All HMEs and filters have ISO s...
...he Portex® Thermovent® T helps provide pro...patient. It is small and extremely lightweight mak...adults. With a high rate of heat and moisture reco...tion retention., ,All HMEs and filters have ISO s...
...even digital models cover the range from 2ul to 50...ume lock design prevents inadvertent volume change...ip. Whole pipette is autoclavable at 121C(250F). ...ropylene. Suitable for one-handed operation. Aut...
...he AlphaPette Pipettor is the #1 Pipettor for sub-...comfort, and reliability. Continuously adjustable....dout sub-micrometer. Easy interchangeable ejector ...le rapid pipet tip ejector with three different le...
Medicine Products: